Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against F5, Inc. regarding possible violations of federal securities laws and unlawful business practices following a significant security breach [1][2]. Investigation Details - On October 15, 2025, F5 disclosed that a sophisticated nation-state threat actor had gained unauthorized access to its systems, including the BIG-IP product development environment and engineering knowledge management platform [2]. - The breach resulted in the exfiltration of certain files, including portions of the BIG-IP source code and information about undisclosed vulnerabilities [2]. - Following this announcement, F5's stock price dropped by $35.40, or approximately 10.70%, from $330.75 to $295.35 within a day [2]. Next Steps - Investors who purchased F5 shares and experienced losses are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and potential claims [3]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Avita Medical, Inc. for possible violations of federal securities laws and unlawful business practices affecting stockholders [1][2]. Investigation Details - The investigation is focused on whether Avita has engaged in practices that may have harmed investors, particularly in light of recent financial disclosures [2]. Financial Performance - On August 7, 2025, Avita reported a significant backlog in unpaid provider claims for its Recell procedures, which negatively impacted demand in the first half of the year [6]. - The backlog was attributed to contractors from the Centers for Medicare & Medicaid Services failing to assign adequate pricing and timely adjudication of claims, leading to uncertainty among providers [6]. - Following this announcement, Avita's stock price fell by $1.13, or approximately 21%, from $5.38 to $4.25 per share [6].

Core Points - Bragar Eagel & Squire, P.C. is investigating potential claims against Freeport-McMoran Inc. regarding possible violations of federal securities laws and unlawful business practices [1][2] Investigation Details - The investigation is focused on Freeport's actions that may have led to losses for stockholders, particularly following a recent incident at the Grasberg Block Cave operation in Indonesia [1][6] - Freeport's stock price dropped by $2.80 per share, or 5.99%, closing at $43.87 per share on September 9, 2025, after the announcement of suspended mining activities due to a blockage that trapped seven workers [6] Next Steps - Investors who purchased Freeport shares and experienced losses are encouraged to contact Bragar Eagel & Squire for more information about their legal rights and potential claims [3]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against America's Car-Mart, Inc. regarding possible violations of federal securities laws and unlawful business practices affecting stockholders [1][2]. Investigation Details - The investigation is focused on whether Car-Mart has engaged in unlawful business practices that may have harmed investors [1][2]. - Investors who have suffered losses and are interested in discussing their legal rights are encouraged to contact the law firm [3]. Company Performance and Stock Impact - On July 15, 2025, Car-Mart announced a delay in filing its annual report due to the need for enhanced disclosures related to loan modifications, resulting in a stock price drop of $3.12 (5.2%) to close at $57.26 [5]. - On July 30, 2025, Car-Mart disclosed that certain previously issued financial statements were no longer reliable, leading to a further stock price decline of $3.70 (7.5%) to close at $45.57 [5]. - On September 4, 2025, Car-Mart reported a 5.7% decline in sales volumes, causing its stock price to fall by $8.14 (18.2%) to close at $36.51 [5].

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against James Hardie Industries plc for possible violations of federal securities laws and unlawful business practices [1][2] Company Financial Performance - On August 19, 2025, James Hardie reported a 29% decline in first-quarter profit for the period ending June 30, 2025, and projected lower-than-expected earnings for fiscal 2026 due to high borrowing costs [5] - Following the announcement, James Hardie's American Depositary Receipt (ADR) price fell by $9.79, or 34.44%, closing at $18.64 per ADR on August 20, 2025 [5] Legal and Investor Relations - Investors who suffered losses from purchasing or acquiring James Hardie shares are encouraged to contact Bragar Eagel & Squire for discussions regarding their legal rights [1][2] - The law firm offers no-cost consultations for affected investors and is seeking information from long-term stockholders [2]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Avita Medical, Inc. for possible violations of federal securities laws and unlawful business practices affecting stockholders [1][2]. Investigation Details - The investigation focuses on whether Avita has engaged in practices that may have harmed investors, particularly in light of recent financial disclosures [2]. Financial Performance - On August 7, 2025, Avita reported a significant backlog in unpaid provider claims for its Recell procedures, which negatively impacted demand in the first half of the year [6]. - The backlog was attributed to contractors from the Centers for Medicare & Medicaid Services failing to assign adequate pricing and timely adjudication of claims, leading to uncertainty among providers [6]. - Following this announcement, Avita's stock price fell by $1.13, or approximately 21%, from $5.38 to $4.25 per share [6].

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against Soleno Therapeutics, Inc. regarding possible violations of federal securities laws and unlawful business practices [1][2] Investigation Details - The law firm is reaching out to Soleno stockholders who have suffered losses, encouraging them to discuss their legal rights and options [1][2] - There is no cost or obligation for stockholders to inquire about their rights or the ongoing investigation [2] Company Background - Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California, representing individual and institutional investors in various complex litigations [3] Recent Events - On August 15, 2025, Scorpion Capital published a report labeling Soleno's product, Vykat XR, as overpriced and potentially unsafe for children, leading to a significant drop in Soleno's stock price by $5.73 per share, or 7.41%, closing at $71.63 [5]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Lesaka Technologies, Inc. for possible violations of federal securities laws and unlawful business practices following a significant restatement of financial statements [1][2]. Investigation Details - On September 10, 2025, Lesaka announced that its Audit Committee concluded that the unaudited condensed consolidated financial statements for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025, should be restated due to a re-evaluation of revenue classification [2]. - The restatement indicates that certain revenue was reported as an agent rather than as a principal, affecting the related cost of goods sold, leading to a drop in Lesaka's stock price [2]. Next Steps - Investors who purchased or acquired Lesaka shares and suffered losses are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and potential claims [3]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against MediaAlpha, Inc. for possible violations of federal securities laws and unlawful business practices [1][2]. Investigation Details - The investigation is prompted by allegations from Wolfpack Research that MediaAlpha engaged in consumer fraud, particularly in its health insurance segment, using deceptive advertising and websites [5]. - Wolfpack Research claims that up to 78% of MediaAlpha's health insurance lead-buying partners are involved in fraudulent activities [5]. - Following these allegations, MediaAlpha's stock price experienced significant declines, dropping 11.84% after the initial report and 27.7% after the FTC's letter regarding misleading claims [5]. Legal Developments - On November 4, 2024, MediaAlpha received a letter from the FTC indicating a recommendation to file a complaint against the company for false representations and deceptive advertising practices [5]. - On August 6, 2025, MediaAlpha announced a settlement with the FTC for $45 million, related to claims of misleading consumers regarding health insurance quotes and the sale of their personal information [5]. - The FTC reported that MediaAlpha sold approximately 119 million leads about consumers in 2024 alone [5].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Roblox Corporation for possible violations of federal securities laws and unlawful business practices, particularly in light of a lawsuit filed by the State of Louisiana regarding child safety on its platform [1][3]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Roblox to contact them to discuss their legal rights [1][4]. - The investigation focuses on whether Roblox has engaged in unlawful business practices that may have harmed investors [1]. Group 2: Lawsuit Details - The State of Louisiana filed a lawsuit against Roblox on August 14, 2025, alleging that the company fails to protect children from predators on its gaming platform [3]. - Louisiana Attorney General Liz Murrill criticized Roblox for prioritizing user growth and profits over child safety, claiming that the platform is filled with harmful content and child predators [3]. - Following the lawsuit announcement, Roblox's stock price dropped over 6% on August 15, 2025 [3].